Table 3 Distribution of CVD risk factors, indicators, their occurrence times, and assertions
Risk factors | Indicators | Before DHS | During DHS | After DHS | Continuing | Total | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P | A | Pb | N | Total | P | A | Pb | N | Total | P | A | Pb | N | Total | P | A | Pb | N | Total | |||
O2 | Mention | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 18 | 18 |
Hypertension | Mention | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 526 | 401 | 471 | 0 | 1398 | 1400 |
High Bp | 304 | 0 | 0 | 0 | 304 | 1647 | 0 | 0 | 0 | 1647 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 4 | 1955 | |
Regulate Bp | 56 | 0 | 0 | 0 | 56 | 244 | 0 | 0 | 0 | 244 | 10 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 310 | |
Blood pressure drug | 43 | 1 | 0 | 0 | 44 | 17 | 0 | 0 | 0 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 3 | 64 | |
Diabetes | Mention | 2 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 172 | 558 | 138 | 3 | 871 | 874 |
High blood glucose | 19 | 0 | 0 | 0 | 19 | 20 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 4 | 43 | |
Regulate blood glucose | 8 | 0 | 0 | 0 | 8 | 28 | 0 | 0 | 0 | 28 | 6 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 42 | |
Hypoglycemic drug | 31 | 0 | 0 | 0 | 31 | 8 | 0 | 0 | 0 | 8 | 7 | 0 | 0 | 0 | 7 | 2 | 0 | 0 | 0 | 2 | 48 | |
Dyslipidemia | Mention | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45 | 4 | 24 | 0 | 73 | 73 |
High blood lipids | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 6 | |
Regulate blood lipids | 2 | 0 | 0 | 0 | 2 | 249 | 0 | 0 | 0 | 249 | 5 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 256 | |
Lip-lowering drug | 2 | 0 | 0 | 0 | 2 | 34 | 0 | 0 | 0 | 34 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 37 | |
CKD | Mention | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 17 | 0 | 26 | 26 |
Atherosis | Mention | 3 | 0 | 0 | 0 | 3 | 4 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 136 | 0 | 1 | 0 | 137 | 144 |
OSAS | Mention | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 |
Smoking | Mention | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 231 | 149 | 0 | 0 | 380 | 380 |
Smoking cessation | 5 | 2 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 8 | |
Smoking amount | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 119 | 0 | 0 | 0 | 119 | 120 | |
A2 | Mention | 9 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 52 | 15 | 0 | 0 | 67 | 76 |
Drinking amount | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19 | 0 | 0 | 0 | 19 | 19 | |
FHCVD | Mention | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 10 | 10 |
Age | Mention | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1233 |
Age group | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 626 | |
Gender | Mention | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1909 |